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Edited by Shou-Wei DingAbstract We describe inhibition of HIV replication by a par-
tially double-stranded 54mer oligodeoxynucleotide, ODN, which
consists of an antisense strand targeting the highly conserved
polypurine tract, PPT, of HIV, and a second strand, compatible
with triple-helix formation. Upon treatment of HIV-infected
cells with ODN early after infection no viral nucleic acids, syn-
cytia or p24 viral antigen expression was observed. The ODN-
mediated eﬀect was highly sequence-speciﬁc. The ODN against
HIV-IIIB was eﬀective preferentially against its homologous
PPT and less against the PPT of HIV-BaL diﬀering in two of
24 nucleotides and vice versa. It may be interesting mechanisti-
cally as an antiviral drug.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Retroviruses replicate their viral RNA by concerted action
of the reverse transcriptase (RT) and ribonuclease H (RNase
H). While the RT is synthesizing the complementary cDNA
the RNase H speciﬁcally hydrolyzes the viral RNA in RNA–
DNA hybrids [1–3]. Hereby a special region, the polypurine
tract, PPT, resists to hydrolysis and remains hybridized to
the cDNA [4–6]. The PPT-RNA is used as RNA primer for
initiation of the second strand DNA synthesis and removed la-
ter. The PPT is located adjacent to the unique region at the 3 0-
end (U3). It is one of the most highly conserved sequences of
HIV. The PPT is 25 nucleotides long in its extended form
and consists of two polypurine clusters interrupted by two
non-purines (CU), which are located adjacent to an internal
A. 5 0 of this ACU triplet is the cleavage site of the viral RNase
H (Fig. 1A) [4], the start site for the RT for the second strand
DNA synthesis. Furthermore, the PPT sequence is important
at later stages during replication for recognition by the integr-
ase and integration of the DNA provirus [7]. Thus, ACU is a
sequence of extreme functional importance for three viral en-Abbreviations: as, antisense; ODN, oligodeoxyribonucleotide; PPT,
polypurine tract; RNase H, ribonuclease H; RT, reverse transcriptase;
siRNA, small interfering RNA
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doi:10.1016/j.febslet.2006.05.033zymes, RT, RNase H, and integrase. The PPT RNA–DNA
heteroduplex has some structural peculiarities [8,9] and may
therefore be a preferred recognition site of the RT/RNase H.
We considered the PPT a good target for intervention of
HIV replication and designed an oligodeoxynucleotide
(ODN) targeted to the PPT-RNA consisting of an antisense
strand of 25 nucleotides, linked by four thymidines to a second
strand, which was designed on the basis of Hoogsteen rules for
purines [10] with the exception of the two non-purines CU.
This ODN is a partially self-complementary hairpin-loop-
structured DNA, 54 bases in length (Fig. 1), containing two
small loops, a linker and non-hybridizing ends [6,11,12]. We
showed previously that this ODN, designated as ODN A,
inhibited HIV production, which we interpreted as an antiviral
triple-helix eﬀect [11,12]. The eﬃciency of the antiviral eﬀect
was surprising, long-lasting, superior to an antisense eﬀect,
and without viral breakthrough for several weeks. Further-
more, patient isolates in peripheral blood mononuclear cells
(PBMCs) or viral isolates with drug-resistant RT mutants were
sensitive to this antiviral eﬀect. No DNA provirus was detect-
able [11,12]. Furthermore, we described previously in vitro
studies on the eﬀect of ODN A on the PPT-RNA. At low con-
centrations of ODN A cleavage occurred, while high concen-
trations were inhibitory [6]. We anticipate the intracellular
levels of ODN A to be very low.
Here we extend our previous studies on the antiviral eﬀect of
a hairpin-loop-structured DNA by analyzing a series of mu-
tants of the ODN A. We demonstrate that the sequence and
length of each of the two strands is important, excluding a sim-
ple antisense mechanism. We are describing a phenomenon,
which leads to silencing of viral nucleic acid early after infec-
tion and prevents DNA provirus formation. It is reminescent
of siRNA and may be designated as ‘‘siDNA’’.2. Materials and methods
2.1. Cells and viruses
The cellular assays were performed with the HTLV-1-transformed
T-cell line C81-66/45 [13], kindly provided by R.C. Gallo (Institute
of Human Virology, Baltimore, MD, USA) and PM1, a CD4+T-cell
clone derived from the neoplastic cell line HUT 78, kindly provided by
P. Lusso (San Raﬀaele Scientiﬁc Institute, Milan, Italy) [14]. Cells were
propagated as described [12]. The HIV-1 viral strains used were HIV-1
IIIB and the macrophage-monocyte-tropic viral isolate HIV-1 BaL.
2.2. Oligodeoxynucleotides
The ODNs (see Fig. 1) are targeted to the extended polypurine
tract, PPT, of HIV-1 located at the 3 0 end of the genome, not
the central one [15], which is slightly diﬀerent. They consist of ablished by Elsevier B.V. All rights reserved.
Fig. 1. Sequences of ODNs. (A) The sequence of the extended polypurine tract, PPT, is shown with the cleavage site of the RNase H, 5 0 of the ACU
sequence (vertical arrow, origin of coordinates). The ODN A consists of an antisense ‘‘Watson–Crick’’ strand and a ‘‘Hoogsteen’’ strand linked by
four thymidines. A putative triple-helix is shown. Watson–Crick bonds are shown by vertical bars, Hoogsteen bonds by stars, two non-Hoogsteen
bonds by dots. (B) The sequences of ODN A and its variants are depicted in hypothetical partially self-complementary hairpin-loop structures.
Curved lines symbolize the linker consisting of four thioated thymidines. Cells were infected with HIV IIIB and two hours later treated with ODNs
(2 lM). Supernatants were collected for two to three weeks and viral core antigen p24 determined by ELISA, cytopathic eﬀect (CPE) by light
microscopy. The PCR results listed are summarized from Figs. 2 and 3 or data not shown. (+) indicates presence of PCR product, CPE and viral
growth, and () negative results due to antiviral eﬀect. Abbreviations: I, internal deletion; rev, reverted; sc, scrambled; comp, complementary; NT, no
tetrades; underlines indicate changes. ODN M and ODN T were used as control. (C) Same as Fig. 1A and B except for HIV-BaL. (D) Sequence
alignment of PPTs. Numbers indicate the incidence of the sequences in 2094 PPT of HIV-1 subtype B analyzed.
3546 K. Moelling et al. / FEBS Letters 580 (2006) 3545–355025mer antisense, and a 25mer putative triple helix-forming ‘Hoogs-
teen’ strand, connected by four thymidines. The sequence is
partially complementary (see Fig. 1B). The ODNs were phos-phorothioated at either end (3 bases each), and in the T4 linker.
The ODNs were purchased from MWG-Biotech, Ebersberg,
Germany.
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A in cell culture
Experiments were performed as described previously [11,12]. Brieﬂy,
2 · 105 cells of the T-lymphocyte cell-line C81-66/45 were infected with
HIV-1 IIIB strain [13], with a MOI of 0.01. In a similar way 2 · 105
PM1 cells were infected with HIV-1 BaL [14] with a MOI of 0.1.
One to two hours post infection cells were washed and treated with
ODNs at 2 lM concentration or 1 lM for ODN A2, respectively. In
the case of Fig. 3B ODNs were added twice, 2 and 24 h post infection.
Cells were kept as described [11,12]. Syncytia formation was monitored
by microscopy and viral p24 antigen determined as described previ-
ously [12].
2.4. Determination of HIV viral nucleic acids by nested PCR, RT-PCR
and real time PCR
Kinetic analysis of RNA/DNA intermediates of replication was car-
ried out with C81-66/45 cells, which were infected with HIV-1 IIIB, or
PM1 cells infected with HIV-1 BaL as described above, and incubated
as indicated. ODNs were added to a ﬁnal concentration of 2 lM at 0.5
or 1 h after infection. Samples were taken before infection or post
infection at the times indicated. For isolation of nucleic acids RNeasy
Mini Kit (Qiagen, Valencia, CA, USA) and for RT-PCR or PCR Ac-
cess RT-PCR Kit (Promega, Madison WI, USA) was used according
to the manufacturer. Extracted nucleic acids consisted of RNA and
DNA. Kinetics of virus infection for HIV-1 IIIB were analyzed using
the primer sets PU3, which gives rise to PCR products of 136 bp
(nested), PPU primers giving rise to 612 bp and 109 bp (nested), and
PPT-B primers leading to 273 bp (see schemes in Fig. 2A–C). Further-
more, the primers PU3.1 and PU3.4 yields a product of 328 bp
(Fig. 2D, top). Primers for PU3 were: outer primers: PU3.1 (23–
42 bp): 5 0-GTAGTGTGATTGGATGGCCT and PU3.2 (891–
910 bp): 5 0-CCACACTGACTAAAAGGGTC, inner primers: PU3.3
(214–243 bp): 5 0-CCTCAGGTACCTTTAAGACC and PU3.4 (331–
350 bp): 5 0-GTGTGGTAGATCCACAGATC; for PPU: outer prim-
ers: PPU-1 (298–320 bp): 5 0-CTAATTCACTCCCAAAGAAGACA
and PU3-2 (see above), inner primers: PPU-2 (331–350 bp): 5 0-GAT-
CTGTGGATCTACCACAC and PPU-3 (421–440 bp): 5 0-GGTAC-
TAGCTTGTAGCACCA; for PPT-B: outer primers: PU3-1 (see
above) and PPT-B (277–296 bp): 5 0-CCTTCCAGTCCCCCCTTTTC.
For HIV-BaL the primers used were BaL-1 (3217–3236 bp) 5 0-GAT-
GGGTGGCAAGTGGTCAA and BaL-2 (3611–3630 bp) 5 0-
GTCAGTGGAAATCTGGTCCC, giving rise to 413 bp. Coordinates
for HIV-1 IIIB-speciﬁc primers refer to Accession No. X03187 and for
BaL-speciﬁc primers to Accession No. M68893. A control for equal
recovery of RNA was performed using GAPDH primers: GAPD-1:
5 0-CCGTCTAGAAAAACCTGCCA and GAPD-2: 5 0-GAG-
CTTGACAAAGTGGTCGT. Primers were purchased from Birsner
and Grob – Biotech GmbH, Freiburg, Germany. Controls (Cont. in
Figs. 2, 3) were performed without ODN and virus (0 h) or with virus
indicated by time post infection (1 or 0.5 h).
The amount of HIV-speciﬁc RNA was quantiﬁed by a real-time
PCR assay (Fig. 2D, bottom) using the ABI 7300 instrument (Applied
Biosystems, Foster City, CA, USA). Sequences of PCR primers (whichFig. 2. Analysis of viral nucleic acids during infection. (A) Cells
infected with HIV-1 IIIB were treated with ODN A for the indicated
periods of time post infection. Nested RT-PCR products (upper panel,
136 bp) or PCR products (lower panel, 136 bp) using primer set PU3
are shown in duplicates. The reactions for diﬀerent primer sets are
depicted schematically at the bottom. (B) Longer term analysis of cells
infected with HIV-1 IIIB treated 2 h post infection with the indicated
ODNs and analyzed 3, 5, 7, and 25 h later. RT-PCR of GAPDH is
shown as control. (C) Short term analysis of HIV-1 IIIB-infected cells
treated with ODN by PCR, nested PCR or RT-PCR using primer sets
PU3 ﬂanking the PPT, PPU for downstream (612 and 109 bp) and
PPT-B for upstream regions of the PPT (273 bp) and GAPDH
(180 bp) as control. (D top) An RT-PCR reaction using primers PU3.1
and PU3.4 leading to a 328 bp PCR fragment as shown in the scheme
was performed by using HIV-1-infected cells 7 days post infection and
two treatments of ODNs (time 0 and 2 h post infection). The lower
panel shows GAPDH PCR control reactions. (D bottom) The graph
shows the analysis by real time PCR for quantiﬁcation of the RNA
using primer sets as described in Section 2.
ccover region close to PPT) and probe were the following: For1
5 0-GAGGAGGTGGGTTTTCCAGT, Rev1: 5 0-GGGAGTGAAT-
TAGCCCTTCC, probe: FAM-ACCTTTAAGAACCAATGACT-
TACAAGGCAGC-TAMRA. Primers were purchased from Operon,
Cologne, Germany. The RT-PCR reactions were performed with the
AMV-RT from a commercially available kit (Promega Co). The test
system was not aﬀected by ODNs (data not shown). The sequence of
the control ODN CO targeted to a region 10 nucleotides downstream
3548 K. Moelling et al. / FEBS Letters 580 (2006) 3545–3550of the PPT, is: 3 0-AGTGAGGGTTTCTTCTGTTCATGGG(T4)-
CCCTCGAATTGAAGAATAAACCTCC-5 0. It has a putative hair-
pin-loop structure similar to ODN A (see Fig. 1).3. Results
3.1. Inhibition of HIV-1 replication by ODN A
HIV-1 replication was analyzed in the T-cell line C81-66/45
T-cells [13] by infecting them with HIV-1 IIIB. Subsequently
the cells were treated with ODNs. The sequential order should
prevent their interference with viral entry. A number of ODN
mutants were designed and are shown as hypothetical partial
self-complementary structures containing two bulges, non-
hybridizing ends and a T4 linker. The ODN A consists of an
antisense strand and a second strand with a selection of nucle-
otides based on Hoogsteen bonds. Several ODNs are presented
and nucleotide changes are indicated by underlining (Fig. 1A
and B). The eﬀects of several ODNs were determined by
PCR, ELISA for p24 core antigen, cytopathic eﬀect (CPE),
or syncytia formation as marker for HIV (listed in Fig. 1B).
Two controls not related to the PPT are shown, an ODN M
(against a murine viral PPT) and an ODN CO, targeted to a
region 10 bases downstream of the PPT. ODNs speciﬁc for
HIV-BaL and controls are shown in Fig. 1C. The HIV PPTs
were aligned using the Los Alamos database, showing their
importance by their high degree of conservation (Fig. 1D).
Among the ODNs listed only ODN A and one variant,
ODN A(C to G), were able to inhibit p24 antigen production,
syncytia formation, and PCR or RT-PCR product synthesis.
The C to G exchange would be compatible with triple-helix
rules. However, ODN D or the shortened ODNs are as com-ig. 3. Analysis of ODNs on HIV-1 BaL infected cells. (A) Similar to Fig. 2B except that HIV-1 BaL and PM1 cells were used and RT-PCR was
erformed using the primer set BaL yielding a 413 bp product after the 1st run. The HIV-1 BaL speciﬁc ODN A2 was tested in comparison to the
ontrol ODN A2rev (left) and compared with the HIV-1 IIIB-speciﬁc ODN A (right). (B) p24 antigen determination as marker for HIV in the
upernatant from C81/66-45 cells infected with HIV-IIIB (left) and PM1 cells infected with HIV-1 BaL (right). Virus was added at time 0, ODNs were
dded twice, 2 and 24 h later. Left: ODN A (s), ODN A2 (d), ODN A2rev (e), ODN D (n), ODN sc (h), no ODN (¯), right: same as left except
DN A2 (2 lM and 1 lM, black and grey dots) and no ODN D. Syncytia formation was evaluated by microscopic inspection and was graded






(+patible with a triple-helix design as ODN A – yet are ineﬀec-
tive. Therefore we do not know whether a triple-helix is in-
volved. All other changes of ODN A abrogated the
inhibitory eﬀect, such as shortening of the ends, exchanges of
nucleotides, or changes in number of bonds (ODN D and
D1). A nucleotide exchange near the 5 0end (ODN A(C to
T)), or internally (ODN D and D2), abrogated the antiviral ef-
fects. These ODNs have antisense strands like ODN A and are
fully complementary to the RNA. Yet their second arms are
mutated, which abrogates their antiviral eﬃcacy. Surprising
was the importance of the sequence and length of the second
arm, demonstrating that the mechanism is not only a classical
antisense eﬀect. It is reminescent of siRNA.
In order to analyze the time course of the eﬀect of the ODNs
we infected cells with HIV-IIIB at time 0, and treated them
with ODNs without carrier 0.5 h later, to prevent interference
of ODNs with virus uptake. The cells were lysed 2.5, 4.5, 6.5 h
after infection and PCR or RT-PCR analysis were performed
(Fig. 2A). We also tested longer periods for up to 25 h
(Fig. 2B) or shorter periods (Fig. 2C). The time course shows
some variation at early time points depending on the individ-
ual experiments. As internal standards we used GAPDH as
controls. The primers were selected to allow ampliﬁcation
products spanning the PPT, another pair downstream of the
PPT, and a third one including the PPT. The reactions are
indicated schematically at the bottom. The result shows that
the presence of ODN A resulted in disappearance of HIV-spe-
ciﬁc nucleic acids very early after virus infection.
A comparison between RT-PCR and quantitative real time
PCR was performed with C81-66/45 cells infected with HIV
and treated with the ODNs at time 0 and 2 h post infection.
The cells were lysed after 7 days for the assay. The result of
K. Moelling et al. / FEBS Letters 580 (2006) 3545–3550 3549the analysis shows a strongly reduced virus-speciﬁc signal with
ODN A and not with the control ODNs, as determined by RT-
PCR analysis (Fig. 2D, top) and quantitative real-time PCR
(Fig. 2D bottom). The primer sets are given in Section 2.
3.2. Homologous inhibition
To further characterize the ODN A-speciﬁc antiviral eﬀect,
we investigated a naturally occurring virus variant. We
screened the Los Alamos database for naturally occurring
variants of the PPT. 69% out of 2094 variants of HIV-1 were
100% identical in their extended PPT sequence. We selected
a natural variant, HIV-1 BaL [14], which contains a PPT con-
sisting of 24 instead of 25 nucleotides and two exchanges at po-
sition 11 and 12, (GA instead of AG) compared to HIV-1
IIIB (Fig. 1C).
We designed an ODN A2 against the corresponding ex-
tended PPT of HIV-1 BaL (Fig. 1C), which was tested on
the homologous strain HIV-1 BaL using PM1 cells. The
ODN A2 was added 0.5 h post infection, the cells were lysed
at the times indicated and RT-PCR analysis was performed
(Fig. 3A). As can be seen no PCR product is detectable with
the ODN A2 in contrast to a control ODN A2rev (left) and
ODN A (right).
We then tested ODN A2 as well as ODN A on both virus
strains in long-term cultures by infecting C81-66/45 cells with
HIV-1 IIIB and PM1 cells with HIV-1 BaL. The viruses were
added at time 0, the ODNs were added twice, 2 and 24 h later
as described previously [12]. Inhibition of viral replication was
observed much more eﬃciently for the homologous than for
the heterologous combinations of virus and ODNs as deter-
mined by p24 antigen expression and syncytia formation
(Fig. 3B). We conclude, that the antiviral eﬀect of the ODNs
on virus replication is highly sequence-speciﬁc.4. Discussion
We describe the disappearance of viral nucleic acids shortly
after HIV infection due to treatment with a highly specialized
DNA oligonucleotide, ODN A. The design of the ODN A was
originally based on rules for a triple-helix [10], and led to a
hypothetical partially self-complementary structure with two
bulges and unpaired ends in the absence of a target RNA.
We do not know whether a triple-helix is formed inside the cell,
because the two non-purines and DNA–RNA–DNA hybrids
may not be stable or may only form transiently. Triple-helix
formation inside a cell has never been shown to occur
[16,17]. A triple-helix has been described previously in vivo
for a subregion of the PPT DNA of HIV, however, only after
cross-linking and stabilization of the structure before insertion
into the cell [16]. Based on our previous in vivo observations
[11,12] and a later report [18], we performed studies with a
number of mutants of the ODN and on the time course of
the eﬀect. Even in cases where the antisense strand was identi-
cal to that of ODN A and fully complementary to the viral
RNA no antiviral eﬀect was observed, suggesting some mech-
anism not only based on a classical antisense eﬀect, since the
second arm is also important.
We attribute the ODN A-mediated antiviral eﬀect to inhibi-
tion of DNA provirus formation [12]. The molecular mecha-
nism behind it may be complex. Preliminary evidence
indicates that the viral RT/RNase H contributes to the antivi-ral eﬀect. The enzyme is specialized to recognize a hybrid at the
PPT for initiation of the second DNA strand. Such a hybrid
may be formed by ODN A binding to the viral RNA, thereby
allowing cleavage of the RNA by the viral RNase H. Primer
extension may then lead to further hydrolysis of the viral
RNA. This would destroy the viral RNA before a correct
cDNA copy was made. The observed importance of the length
of the ODN A may be due to structural constraints of the RT/
RNase H to ﬁt to the PPT [4,8].
Also the cellular RNase H1 may contribute to such a hydro-
lysis if a transient RNA–DNA hybrid is formed [19]. The
importance of the second arm of the ODN and its sequence-
speciﬁcity may be attributed to protection against nucleases
until it is targeted to the viral RNA.
We even consider the possibility that the RNase H-like activ-
ity assigned recently to the PIWI domain of the Argonaute
protein, may contribute to the antiviral eﬀect. The PIWI do-
main is the active component for cleavage of the target RNA
by small interfering RNA. It has an RNase H-like structure
and an RNase H activity under special assay conditions
[20,21]. Unspeciﬁc interference of the ODNs with viral uptake
can be excluded because inhibition of each virus strain oc-
curred preferentially by its homologous ODNs.
An RNA–DNA hybrid formation is thermodynamically fa-
vored over double-stranded DNA, especially since we used a
hairpin-loop-structured DNA [22], which may more easily
open up than a double-strand. Hybridization may even be fur-
ther supported by the presence of the nucleocapsid. We and
others have shown that the nucleocapsid is a matchmaker or
chaperone, which strongly enhances the rate of cleavage and
turnover of viral RNA by a ribozyme [23,24]. It may play a
role here as well. Whether the nucleocapsid could also support
a triple-helix formation is not known. We cannot easily test
such a structure to evaluate its contribution to the antiviral
eﬀect.
In summary, we describe an antiviral eﬀect by a highly spe-
cialized hairpin-loop-structured ODN. The partial double-
strand may protect the ODNA against nucleases. When
targeted to the PPT several enzymes of viral and cellular origin
may contribute to the antiviral eﬀect. Since the PPT is one of
the most highly conserved regions of HIV, the ODNA may be
interesting for further studies or potentially for development of
a drug.
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